Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Romo

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Neuro-Oncology Practice|December 29, 2025
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomasMaria Ioannou, Setu Mehta, Anirudra Devkota, et al.
The Journal of Investigative Dermatology|June 15, 2023
Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1Chunhui Jiang, Renée M McKay, Sang Y Lee, et al.
The Journal of Investigative Dermatology|June 24, 2023
A Call for Discovery and Therapeutic Development for Cutaneous NeurofibromasJaishri O Blakeley, Lu Q Le, Sang Y Lee, et al.
Neuro-Oncology Advances|April 14, 2025
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomasStuart A Grossman, Carlos G Romo, Xiaobu Ye, et al.
JAMA Dermatology|August 28, 2024
Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1Michelle Jade Lin, Hanqi Yao, Katya Vera, et al.
The Journal of Investigative Dermatology|May 28, 2023
RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological InsightsSteven D Rhodes, Frank McCormick, Ross L Cagan, et al.
The Journal of Investigative Dermatology|June 9, 2023
Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous NeurofibromasIna Ly, Carlos G Romo, Sally Gottesman, et al.
The British Journal of Dermatology|November 25, 2025
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-DLaura Fertitta, Kavita Y Sarin, Carlos G Romo, et al.
Neuro-Oncology|November 5, 2024
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1Calixto-Hope G Lucas, Andrea M Gross, Carlos G Romo, et al.
Neurosurgical Focus|May 1, 2025
Surgical management of schwannomas in schwannomatosis: a comprehensive analysis of clinical outcomes and determinants of local recurrenceAbdel-Hameed Al-Mistarehi, Kelly Jiang, Jawad M Khalifeh, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Neuro-Oncology Practice|December 29, 2025
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomasMaria Ioannou, Setu Mehta, Anirudra Devkota, et al.
The Journal of Investigative Dermatology|June 15, 2023
Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1Chunhui Jiang, Renée M McKay, Sang Y Lee, et al.
The Journal of Investigative Dermatology|June 24, 2023
A Call for Discovery and Therapeutic Development for Cutaneous NeurofibromasJaishri O Blakeley, Lu Q Le, Sang Y Lee, et al.
Neuro-Oncology Advances|April 14, 2025
Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomasStuart A Grossman, Carlos G Romo, Xiaobu Ye, et al.
JAMA Dermatology|August 28, 2024
Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1Michelle Jade Lin, Hanqi Yao, Katya Vera, et al.
The Journal of Investigative Dermatology|May 28, 2023
RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological InsightsSteven D Rhodes, Frank McCormick, Ross L Cagan, et al.
The Journal of Investigative Dermatology|June 9, 2023
Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous NeurofibromasIna Ly, Carlos G Romo, Sally Gottesman, et al.
The British Journal of Dermatology|November 25, 2025
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-DLaura Fertitta, Kavita Y Sarin, Carlos G Romo, et al.
Neuro-Oncology|November 5, 2024
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1Calixto-Hope G Lucas, Andrea M Gross, Carlos G Romo, et al.
Neurosurgical Focus|May 1, 2025
Surgical management of schwannomas in schwannomatosis: a comprehensive analysis of clinical outcomes and determinants of local recurrenceAbdel-Hameed Al-Mistarehi, Kelly Jiang, Jawad M Khalifeh, et al.
Pageof 7